Sector ratings GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 2,877.40 INR | +6.46% |
|
+10.63% | +16.32% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,055B | A | |||||||
| 632B | - | BBB | - | - | ||||
| 442B | AA | - | ||||||
| 351B | AA | |||||||
| 290B | AAA | |||||||
| 243B | A | |||||||
| 227B | A | |||||||
| 200B | A | |||||||
| 172B | AA | |||||||
| 153B | A | |||||||
| 132B | A | |||||||
| 131B | AA | |||||||
| 106B | AA | |||||||
| 101B | AA | |||||||
| 70.87B | AA | |||||||
| 55.24B | AA | |||||||
| 54.51B | AA | |||||||
| 51.66B | AA | |||||||
| 42.49B | - | |||||||
| Average | 237.37B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
